Loading...
XASEINFU
Market cap174mUSD
Dec 24, Last price  
8.21USD
1D
0.74%
1Q
37.75%
Jan 2017
221.96%
IPO
52.04%
Name

InfuSystem Holdings Inc

Chart & Performance

D1W1MN
XASE:INFU chart
P/E
200.20
P/S
1.39
EPS
0.04
Div Yield, %
0.00%
Shrs. gr., 5y
0.21%
Rev. gr., 5y
13.38%
Revenues
126m
+14.44%
006,582,00035,415,00038,964,00047,229,00054,637,00058,828,00062,280,00066,487,00072,125,00070,497,00071,077,00067,138,00081,115,00097,388,000102,382,000109,914,000125,785,000
Net income
872k
+4,744.44%
-24,783-7,859,344-2,796,0009,959,000774,000-1,852,000-45,443,000-1,489,0001,669,0003,357,0003,743,000-222,000-20,707,000-1,095,0001,361,00017,332,0001,420,00018,000872,000
CFO
11m
-35.93%
-76-912,3534,377,00010,897,0009,708,00010,812,0007,172,0005,452,0007,463,0007,255,0007,054,0007,909,0007,583,00011,391,00013,875,00020,280,00018,316,00017,517,00011,223,000
Earnings
Mar 12, 2025

Profile

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
IPO date
Jun 15, 2006
Employees
420
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
125,785
14.44%
109,914
7.36%
102,382
5.13%
Cost of revenue
120,707
105,679
95,223
Unusual Expense (Income)
NOPBT
5,078
4,235
7,159
NOPBT Margin
4.04%
3.85%
6.99%
Operating Taxes
979
112
(163)
Tax Rate
19.28%
2.64%
NOPAT
4,099
4,123
7,322
Net income
872
4,744.44%
18
-98.73%
1,420
-91.81%
Dividends
Dividend yield
Proceeds from repurchase of equity
(1,311)
(5,297)
(608)
BB yield
0.57%
2.83%
0.16%
Debt
Debt current
1,474
931
349
Long-term debt
40,699
40,679
40,088
Deferred revenue
27,496
28,346
Other long-term liabilities
(33,157)
(32,748)
Net debt
41,942
(2,760)
(1,717)
Cash flow
Cash from operating activities
11,223
17,517
18,316
CAPEX
(1,024)
(15,076)
(16,656)
Cash from investing activities
(6,734)
(11,478)
(21,315)
Cash from financing activities
(4,423)
(6,060)
(6,463)
FCF
36,006
3,009
272
Balance
Cash
231
165
186
Long term investments
44,205
41,968
Excess cash
38,874
37,035
Stockholders' equity
(57,535)
(57,853)
(53,633)
Invested Capital
146,211
138,044
134,270
ROIC
2.88%
3.03%
5.60%
ROCE
5.73%
4.93%
8.42%
EV
Common stock shares outstanding
21,646
21,547
22,050
Price
10.54
21.43%
8.68
-49.03%
17.03
-9.32%
Market cap
228,150
21.99%
187,031
-50.19%
375,506
-7.93%
EV
270,092
184,271
373,789
EBITDA
17,586
17,595
21,784
EV/EBITDA
15.36
10.47
17.16
Interest
2,170
1,402
1,377
Interest/NOPBT
42.73%
33.11%
19.23%